General topics
| No. | TOPIC |
|---|---|
| 1 | Haematopoietic Stem Cells |
| 2 | Stem Cell Mobilization, Collection and Engineering |
| 3 | CAR-based Cellular Therapy – Preclinical |
| 4 | CAR-based Cellular Therapy – Clinical |
| 5 | Cellular Therapies other than CARs |
| 6 | Experimental Transplantation and Gene Therapy |
| 7 | New Drugs- and Cell-based Immune Therapies |
| 8 | Non-haematopoietic Stem Cells and Regenerative Medicine |
Transplant-specific topics
| no. | TOPIC |
|---|---|
| 9 | Stem Cell Source |
| 10 | Stem Cell Donor |
| 11 | Graft-versus-host Disease – Preclinical and Animal Models |
| 12 | Graft-versus-host Disease – Clinical |
| 13 | Infectious Complications |
| 14 | Non-infectious Early Complications |
| 15 | Non-infectious Late Effects, Quality of Life and Fertility |
| 16 | Conditioning Regimens |
| 17 | Minimal Residual Disease, Tolerance, Chimerism and Immune Reconstitution |
| 18 | Paediatric Issues |
Disease-specific topics
| no. | TOPIC |
|---|---|
| 19 | Acute Leukaemia |
| 20 | Aplastic Anaemia |
| 21 | Autoimmune Diseases |
| 22 | Myeloproliferative Neoplasm |
| 23 | Haemoglobinopathy |
| 24 | Inborn Errors, Granulocyte and Osteoclast Disorders |
| 25 | Immunodeficiency Diseases and Macrophages |
| 26 | Lymphoma and Chronic Lymphocytic Leukemia |
| 27 | Multiple Myeloma |
| 28 | Myelodysplastic Syndromes |
| 29 | Chronic Leukaemia and Other Myeloproliferative Disorders |
| 30 | Solid Tumours |
Other topics
| no. | TOPIC |
|---|---|
| 31 | Data Management |
| 32 | Statistics |
| 33 | Quality Management |
| 34 | Patient Advocacy: Patients' Reported Outcome and Expectations |
| 35 | Psychological Issues |
| 36 | Pharmacology |
Care-specific topics
| no. | TOPIC |
|---|---|
| 37 | Care of the Carer (Healthcare Team and Caregiver) |
| 38 | Complementary Therapies |
| 39 | Donor Care |
| 40 | Ethical Issues |
| 41 | Impact of New Therapies on Patient Care |
| 42 | Education and Training |
| 43 | Management |
| 44 | Outpatient Developments and Ambulatory Care |
| 45 | Palliative and End-of-life Care |
| 46 | Patient Safety and Standards of Care |
| 47 | Psycho-social Issues |
| 48 | Vaccination, Infection Control and Prevention |
| 49 | Quality of Life, Late Effects, Survivorship Care and Health Promotion |
| 50 | Symptom Management |
| 51 | CAR-T or Immune Effector Cells |
| 52 | Quality Management and JACIE |
| 53 | Transplant. CAR-T Coordination and Follow-up |
| 54 | Advanced Nursing Practice |
| 55 | Nursing Research and Audit in Transplant and CAR-T |
| 56 | Digital Solutions in HSCT Nursing |
| 57 | Patient and Donor Information |
| 58 | Paediatric and AYA/TYA Care |
| 59 | Outreach Programmes for HSCT in LMICs |